Marketing Authorization Application for 3-antigen prophylactic Hepatitis B vaccine submitted to European Medicines Agency

This vaccine is the only 3-antigen hepatitis B vaccine, comprised of the S, pre-S1, and pre-S2 surface antigens of the hepatitis B virus. Approval is sought for the prevention of infection caused by all known subtypes of the hepatitis B virus in adults.

Source:

Biospace Inc.